


Chemicals & Petrochemicals | Small Cap
Bodal Chemicals Ltd, operating within the Chemical & Petrochemicals industry, demonstrates a mixed financial performance. The company shows strong solvency and growth, driven by significant increases in revenue, operating profit, and earnings per share. Profitability is also a notable strength, supported by healthy gross profit and operating margins. However, liquidity is a significant concern, with all key liquidity ratios indicating poor short-term financial health. Efficiency is also an area of concern, with low turnover ratios for fixed assets, inventory, and receivables. The company's coverage ratios are weak, reflecting challenges in meeting interest and dividend obligations. While financial metrics show some positive signs in capital expenditures, adjusted earnings and dividends are areas of concern. Overall, Bodal Chemicals exhibits potential for growth and profitability but needs to address its liquidity and efficiency challenges to ensure long-term stability. The company's reliance on equity and strong asset growth are positive indicators, but a more balanced financial strategy is needed to mitigate risks.
Bodal Chemicals Ltd, operating within the Chemical & Petrochemicals industry, demonstrates a mixed financial performance. The company shows strong solvency and growth, driven by significant increases in revenue, operating profit, and earnings per share. Profitability is also a notable strength, supported by healthy gross profit and operating margins. However, liquidity is a significant concern, with all key liquidity ratios indicating poor short-term financial health. Efficiency is also an area of concern, with low turnover ratios for fixed assets, inventory, and receivables. The company's coverage ratios are weak, reflecting challenges in meeting interest and dividend obligations. While financial metrics show some positive signs in capital expenditures, adjusted earnings and dividends are areas of concern. Overall, Bodal Chemicals exhibits potential for growth and profitability but needs to address its liquidity and efficiency challenges to ensure long-term stability. The company's reliance on equity and strong asset growth are positive indicators, but a more balanced financial strategy is needed to mitigate risks.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
26.28
Industry Median
22.59
Small Cap Median
21.70
P/E RATIO
50.41
P/B RATIO
0.83
Industry Median
1.76
Small Cap Median
1.77
P/S RATIO
0.54
Industry Median
0.89
Small Cap Median
0.88
Others
PEG RATIO
-2.45
EV/EBITDA RATIO
5.49
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹74.11 as on Jun 15, 2026.
The company demonstrates strong growth. High growth rates in revenue, operating profit, and earnings per share indicate robust expansion and profitability. This suggests effective strategies in capturing market opportunities and enhancing shareholder value. However, it's important to ensure that this growth is sustainable and supported by efficient operations and financial stability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 67.62 | -23.41 | -11.37 | 25.09 | 15.3 |
| Operating Profit Growth Rate | 152.87 | -39.55 | -16.54 | 50.45 | -3.59 |
| Earnings Per Share (EPS) Growth | 148.1 | -64.39 | -83.17 | 188.24 | 158.5 |
| Asset Growth Rate | 20.81 | 0.33 | 7.59 | 2.54 | 0.73 |
| Net Income Growth Rate | 147.5 | -61.62 | -84.21 | 200 | 166.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Bhageria Industries Ltd | 8.52 | 21.43 | Neutral | 91.00 | 11.52 | 44.00 |
| 2 | Ducol Organics & Colours Ltd | 7.61 | 23.99 | Neutral | 14.00 | 2.49 | 7.00 |
| 3 | Bodal Chemicals Ltd | 6.19 | 50.41 | Undervalued | 161.00 | 3.74 | 48.00 |
| 4 | Asahi Songwon Colors Ltd | 5.13 | 16.94 | Undervalued | 50.00 | 19.05 | 18.00 |
| 5 | Heubach Colorants India Ltd | 3.63 | 3.25 | Highly Undervalued | 56.00 | 20.21 | 40.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT